HCM Academy is an independent educational initiative supported by grant funding from Bristol Myers Squibb, Cytokinetics, iRhythm Technologies, Sanofi and Tenaya Therapeutics. PCM Scientific is the organiser and all content is created by the faculty. No funder has had input into any content or activity.

Patient Story

Willie

Willie is 56 and a former Olympic athlete who received an early diagnosis of HCM through a routine check up. When he began to experience symptoms 15 years after his diagnosis, he managed it with medication but over time became refractory to medical management.

Following several bouts of atrial fibrillation, issues with blood clots and risk of lung damage, Willie needed a heart transplant.

Watch his story as he shares his experiences.